Pure Global

"Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens - Taiwan Registration f0dc857e4dddace0001b166efc414663

Access comprehensive regulatory information for "Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number f0dc857e4dddace0001b166efc414663 and manufactured by Johnson & Johnson surgical Vision, Inc.;; AMO PUERTO RICO MANUFACTURING, INC.. The authorized representative in Taiwan is AMO ASIA LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Johnson & Johnson Surgical Vision, Inc.;; AMO Groningen B.V., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1 Competitors
1 Recent Registrations
f0dc857e4dddace0001b166efc414663
Registration Details
Taiwan FDA Registration: f0dc857e4dddace0001b166efc414663
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens
TW: โ€œ็œผๅŠ›ๅฅโ€ๆทป่ฆ–ๆ˜Žๆ–ฐ่ฆ–ๅปถๆ•ฃๅ…‰็Ÿฏๆญฃๅ–ฎ็‰‡ๅž‹ไบบๅทฅๆฐดๆ™ถ้ซ”
Risk Class 3

Registration Details

f0dc857e4dddace0001b166efc414663

DHA05603375806

Product Details

For details, it is Chinese approved copy of the imitation order

M Ophthalmology

M.3600 Artificial Crystal

Input;; Contract manufacturing

Dates and Status

Jun 09, 2020

Jun 09, 2025

Companies Making Similar Products
Top companies providing products similar to ""Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens"